Companies: 10,795·Total market cap: $144.5T
Harvard Bioscience, Inc.

Harvard Bioscience, Inc.

HBIONASDAQHealthcare● Active
$5.86
$-0.15(-2.50%)
Market Cap$26429655
P/E Ratio
52W High$9.4
52W Low$3.8
Overview

Harvard Bioscience, Inc. (HBIO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HBIO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.20hbio eps ttm · hbio earnings per shareEarnings history
PE Ratio (TTM)hbio pe ratio ttm · hbio price to earningsPE Ratio deep dive
Revenue (TTM)$85.5Mhbio revenue ttm · hbio annual revenueFull revenue history
Dividend YieldNo Dividenddoes hbio pay dividends · hbio dividend yieldDividend history
Shares Outstanding4.4Mhbio shares outstanding · hbio floatShares outstanding history
Next EarningsAug 10, 2026Est.hbio earnings date · hbio next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$86.5M▼ 8.06% YoY
202320242025
harvard bioscience, inc. revenue · hbio revenue 2025
FY 2025Net Income-$56.7M▼ 357.07% YoY
202320242025
harvard bioscience, inc. net income · hbio profit 2025
FY 2025EPS$-12.80▼ 357.14% YoY
202320242025
hbio eps · harvard bioscience, inc. earnings per share 2025
TTM:Revenue: $85.5MNet Income: -$9.8MEPS: $-2.20View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis hbio a buy · hbio analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$5.86Current
$6.00Avg Target2.39% upside
$6.00High
hbio price target · hbio 12 month forecast

Total: 5 · Buy rate: 80.0%

The HBIO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +2.39% upside from the current price of $5.86.

Stock Performance

Full History
1D-2.99%
1W-7.40%
1M-12.90%
3M+23.66%
YTD-10.16%
1Y+7.71%
5Y-92.13%

About Harvard Bioscience, Inc.

CEOJohn Duke
IPO DateMar 19, 2001
Employees330
CountryUS

Harvard Bioscience, Inc. (HBIO) is a global provider of cutting-edge technologies, products, and services crucial for fundamental scientific investigation, drug discovery, and preclinical testing. Ser…

what is harvard bioscience, inc. · hbio stock overview · harvard bioscience, inc. company profile · who is harvard bioscience, inc. ceo · hbio NASDAQ · harvard bioscience, inc. headquarters · harvard bioscience, inc. business segments

About Stock Overview & Key Data

Harvard Bioscience, Inc. (HBIO) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Mar 19, 2001. As of the latest trading session, HBIO stock price is $5.86, with a market capitalization of $26.4M. The stock has returned +7.71% over the past 12 months and -10.16% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Harvard Bioscience, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Harvard Bioscience, Inc. reported revenue of $86.5M and net income of -$56.7M. For detailed data — including Harvard Bioscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Harvard Bioscience, Inc. (HBIO) stock price is $5.86. The stock is traded on NASDAQ under the ticker symbol HBIO. The 52-week range is $3.80 – $9.40.

HBIO stock priceHBIO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice